• Acorda CMO hits the exit, landing Pharnext job with oversight of phase 3 neurological disorder trial

    10 days ago - By Fierce Biotech

    Acorda CMO hits the exit, landing Pharnext job with oversight of phase 3 neurological disorder trial ntaylor
    Wed, 11/24/2021 - 05:52
    Read more ...